ASTRAZENECA PLC (AZN)
Clinical trial NCT04960709: primary completion date: 2026-04-30 → 2026-03-02.
Clinical trial NCT04960709: primary completion date: 2026-04-30 → 2026-03-02.
Clinical trial NCT07443137: start date: 2026-05-01 → 2026-07-01.
Clinical trial NCT03702920 updates: 1. start date: 2019-02-21 → 2019-06-17 2. enrollment: 275 → 274 participants 3. collaborators removed: Instituto Grifols, S.A.
Clinical trial NCT05997615: enrollment: 390 → 437 participants.
Clinical trial NCT05467930: primary completion date: 2026-05-01 → 2027-05-01.
Clinical trial NCT03258658: start date: 2026-05-01 → 2026-08-01.
Clinical trial NCT07488676: start date: 2026-03-20 → 2026-05-04.
Clinical trial NCT05885607 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. completion date: 2026-03-31 → 2027-06-30 3. primary completion date: 2026-02-09 → 2027-02-28
Clinical trial NCT03960840: completion date: 2027-06-30 → 2028-05-31.
Clinical trial NCT04573478 updates: 1. completion date: 2026-12-18 → 2028-04-14 2. primary completion date: 2026-12-18 → 2028-04-14